LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...
Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an early end of the trial extension.
US Weekly on MSN
Chris Hemsworth Struggles With Dad’s Alzheimer’s Diagnosis: ‘A Road Trip to Remember’ Revelations
Chris Hemsworth opens up about his father's early-stage Alzheimer's battle in Chris Hemsworth: A Road Trip to Remember ...
A new study suggests you may want to pay better attention to your HDL cholesterol — but not for the reason you might think.
Two large-scale phase 3 trials found that semaglutide did not significantly slow cognitive decline in early-stage Alzheimer’s ...
Pharmaceutical Technology on MSN
GLP-1RA Alzheimer’s hopes dashed after Novo Nordisk’s semaglutide miss
While the Phase III results confirm prior analyst sentiments, a KOL notes that GLP-1RAs could still show potential in the ...
FOX 32 Chicago on MSN
How to spot signs of Alzheimer's disease in a loved one
Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...
Johnson & Johnson will discontinue the Phase II Auτonomy study of posdinemab after a scheduled review found the anti-tau ...
We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...
Chris Hemsworth's touching road trip with his father Craig, who has "early-stage Alzheimer's," is chronicled in a National ...
A Korean research team has identified the most effective OLED color capable of enhancing cognitive function in Alzheimer's ...
19hon MSN
Novo Nordisk’s oral GLP-1 drug didn’t work on Alzheimer’s as hoped, but don’t call it a failure
Novo Nordisk’s stock tumbles after its oral GLP-1 drug didn’t show a statistically significant benefit over a placebo against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results